Profit & Loss

  • Company Name :
Gennex Laboratories Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 531739
  • NSE Symbol:
  • -
  • P/E(TTM):
  • 21.35
  • ISIN Demat:
  • INE509C01026
  • Div & Yield%:
  • -
  • EPS(TTM):
  • 0.65
  • Book Value(₹):
  • 7.60
  • Market Cap(₹Cr.):
  • 315.70
  • Face Value(₹):
  • 1.00
Particulars Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
INCOME :          
Sales Turnover 74.05 71.35 65.26 63.65 59.96
Excise Duty 7.25 6.25 4.05 4.00 4.34
Net Sales 66.80 65.10 61.21 59.65 55.62
Other Income 4.30 3.40 1.38 0.52 1.06
Stock Adjustments 2.44 7.00 1.91 -1.53 1.51
Total Income 73.54 75.50 64.50 58.64 58.19
EXPENDITURE :          
Raw Materials 41.94 48.14 41.23 35.18 36.20
Power and Fuel Cost 3.29 4.26 3.17 3.01 3.30
Other Manufacturing Expenses 1.06 1.18 0.80 2.14 3.67
Selling and Administration Expenses 2.93 4.40 3.43 3.44 3.34
Miscellaneous Expenses 1.54 1.82 2.15 0.98 0.56
Employee Benefit Expenses 6.05 7.71 6.97 7.21 6.81
Less: Preoperative Expenditure - - - - -
Total Expenses - - - - -
Operating Profit 16.73 7.99 6.76 6.68 4.30
Interest 1.16 1.23 0.88 0.74 0.75
Gross Profit 15.57 6.76 5.88 5.94 3.55
Depreciation 0.81 0.74 0.79 0.88 1.00
Profit Before Tax 14.76 6.02 5.09 5.06 2.55
Current Tax 3.05 1.59 1.32 1.27 0.85
Fringe Benefit tax - - - - -
Deferred Tax -0.09 -0.14 -0.15 -0.25 -0.16
Reported Net Profit 11.80 4.56 3.92 4.04 1.86
Extraordinary Items - 0.04 - -0.28 0.08
Adjusted Net Profit 11.80 4.52 3.92 4.32 1.78
Adjustment below Net Profit - - - - -
Profit/Loss Balance carried down 28.22 23.66 19.74 15.70 13.84
Statutory Appropriations - - - - -
Appropriations - - - - -
P & L Balance carried down 40.02 28.22 23.66 19.74 15.70
Dividend - - - - -
Preference Dividend - - - - -
Equity Dividend (%) - - - - -
Dividend Per Share(Rs) - - - - -
Earnings Per Share-Unit Curr 0.52 0.25 0.31 0.32 0.15
Earnings Per Share(Adj)-Unit Curr 0.52 0.25 0.30 0.31 0.14
Book Value 7.26 4.39 3.48 3.15 2.83
Book Value(Adj)-Unit Curr 7.26 4.39 3.32 3.00 2.69